Olga Grzybowska‐Izydorczyk

Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia

Olga Grzybowska‐Izydorczyk, Barbara Cebula‐Obrzut, Tadeusz Robak et al. · European Journal of Cancer · 2010 · 68 citations

Life Sciences, Hematology, Oncology +16

Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut et al. · European Journal Of Haematology · 2007 · 48 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Polymorphisms of <i>TNF</i> and <i>IL‐10</i> genes and clinical outcome of patients with chronic lymphocytic leukemia

Ewa Lech‐Marańda, Wojciech Młynarski, Olga Grzybowska‐Izydorczyk et al. · Genes Chromosomes and Cancer · 2012 · 32 citations

Life Sciences, Genetics, Molecular Genetics +13

<i>CD38</i>Gene Polymorphisms Contribute to Genetic Susceptibility to B-Cell Chronic Lymphocytic Leukemia: Evidence from Two Case-Control Studies in Polish Caucasians

Krzysztof Jamroziak, Zofia Szemraj, Olga Grzybowska‐Izydorczyk et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 32 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment

Mateusz Nowicki, Agnieszka Wierzbowska, Roman Małachowski et al. · Annals of Hematology · 2017 · 25 citations

Medicine, Hematology, Translational Sciences +13